Primary percutaneous stenting of the bile ducts in patients with resectable perihilar cholangiocarcinoma - a pilot study - TESLA 2 pilot

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 12 人开始时间: 待定最近更新: 2024年7月8日

适应症

试验速览

暂无简介。

•Written informed consent must be given according to ICH/GCP, and
•national/local regulations.
•Resectable pCCA on imaging with histopathological confirmation or high
•clinical suspicion (as determined by the multidisciplinary hepatobiliary team).
•Hyperbilirubinemia (a combination of a total bilirubin level >50 mmol/l.
•Age above 18 years

•Fluctuation or spontaneous decrease of a total bilirubin level before start
•of any treatment suggesting potential benign origin.
•Patients who underwent previous drainage procedures endoscopically or
•percutaneously with an internalized biliary catheter.
•Clinical signs of cholangitis. Cholangitis was defined as the presence of
•both fever (i.e. body temperature >38.5°C) combined with leucocytosis (i.e. >=10
•*109/L) without clinical or radiological evidence of acute cholecystitis
•Uncorrectable coagulation disorder.
•Uncorrectable contrast allergy.

发起方